Effect of time, dose and fractionation on local control of nasopharyngeal carcinoma. 1995

A W Lee, and D K Chan, and J F Fowler, and Y F Poon, and W Foo, and S C Law, and S K O, and S Y Tung, and R Chappell
Institute of Radiology and Oncology, Queen Elizabeth Hospital, Kowloon, Hong Kong.

To study the effect of radiation factors on local control of nasopharyngeal carcinoma, 1008 patients with similarly staged T1N03M0 disease (Ho's classification) were retrospectively analyzed. All patients were treated by megavoltage irradiation alone using the same technique. Four different fractionation schedules had been used sequentially during 1976-1985: with total dose ranging from 45.6 to 60 Gy and fractional dose from 2.5 to 4.2 Gy. The median overall time was 39 days (range = 38-75 days). Both for the whole series and 763 patients with nodal control, total dose was the most important radiation factor. The hazard of local failure decreased by 9% per additional Gy (p < 0.01). Biological equivalents expressed in terms of Biologically Effective Dose or Nominal Standard Dose also showed strong correlation. Fractional dose had no significant impact. The effect of overall treatment time was insignificant for the whole series, but almost reached statistical significance for those with nodal control (p = 0.06). Further study is required for elucidation, as 85% of patients completed treatment within a very narrow range (38-42 days), and the possible hazard is clinically too significant to be ignored.

UI MeSH Term Description Entries
D008198 Lymph Nodes They are oval or bean shaped bodies (1 - 30 mm in diameter) located along the lymphatic system. Lymph Node,Node, Lymph,Nodes, Lymph
D008207 Lymphatic Metastasis Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system. Lymph Node Metastasis,Lymph Node Metastases,Lymphatic Metastases,Metastasis, Lymph Node
D008297 Male Males
D009303 Nasopharyngeal Neoplasms Tumors or cancer of the NASOPHARYNX. Cancer of Nasopharynx,Nasopharyngeal Cancer,Cancer of the Nasopharynx,Nasopharynx Cancer,Nasopharynx Neoplasms,Neoplasms, Nasopharyngeal,Cancer, Nasopharyngeal,Cancer, Nasopharynx,Cancers, Nasopharyngeal,Cancers, Nasopharynx,Nasopharyngeal Cancers,Nasopharyngeal Neoplasm,Nasopharynx Cancers,Nasopharynx Neoplasm,Neoplasm, Nasopharyngeal,Neoplasm, Nasopharynx,Neoplasms, Nasopharynx
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D011879 Radiotherapy Dosage The total amount of radiation absorbed by tissues as a result of radiotherapy. Dosage, Radiotherapy,Dosages, Radiotherapy,Radiotherapy Dosages
D011882 Radiotherapy, High-Energy Radiotherapy using high-energy (megavolt or higher) ionizing radiation. Types of radiation include gamma rays, produced by a radioisotope within a teletherapy unit; x-rays, electrons, protons, alpha particles (helium ions) and heavy charged ions, produced by particle acceleration; and neutrons and pi-mesons (pions), produced as secondary particles following bombardment of a target with a primary particle. Megavolt Radiotherapy,High-Energy Radiotherapy,Radiotherapy, Megavolt,High Energy Radiotherapy,Radiotherapy, High Energy
D012062 Relative Biological Effectiveness The ratio of radiation dosages required to produce identical change based on a formula comparing other types of radiation with that of gamma or roentgen rays. Biological Effectiveness, Relative,Effectiveness, Biologic Relative,Effectiveness, Biological Relative,Relative Biologic Effectiveness,Biologic Effectiveness, Relative,Biologic Relative Effectiveness,Biological Relative Effectiveness,Effectiveness, Relative Biologic,Effectiveness, Relative Biological,Relative Effectiveness, Biologic
D002294 Carcinoma, Squamous Cell A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed) Carcinoma, Epidermoid,Carcinoma, Planocellular,Carcinoma, Squamous,Squamous Cell Carcinoma,Carcinomas, Epidermoid,Carcinomas, Planocellular,Carcinomas, Squamous,Carcinomas, Squamous Cell,Epidermoid Carcinoma,Epidermoid Carcinomas,Planocellular Carcinoma,Planocellular Carcinomas,Squamous Carcinoma,Squamous Carcinomas,Squamous Cell Carcinomas

Related Publications

A W Lee, and D K Chan, and J F Fowler, and Y F Poon, and W Foo, and S C Law, and S K O, and S Y Tung, and R Chappell
January 1998, International journal of radiation oncology, biology, physics,
A W Lee, and D K Chan, and J F Fowler, and Y F Poon, and W Foo, and S C Law, and S K O, and S Y Tung, and R Chappell
April 1985, International journal of radiation oncology, biology, physics,
A W Lee, and D K Chan, and J F Fowler, and Y F Poon, and W Foo, and S C Law, and S K O, and S Y Tung, and R Chappell
March 1998, Japanese journal of clinical oncology,
A W Lee, and D K Chan, and J F Fowler, and Y F Poon, and W Foo, and S C Law, and S K O, and S Y Tung, and R Chappell
June 1976, Cancer,
A W Lee, and D K Chan, and J F Fowler, and Y F Poon, and W Foo, and S C Law, and S K O, and S Y Tung, and R Chappell
February 2011, Zhonghua yi xue za zhi,
A W Lee, and D K Chan, and J F Fowler, and Y F Poon, and W Foo, and S C Law, and S K O, and S Y Tung, and R Chappell
February 1994, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology,
A W Lee, and D K Chan, and J F Fowler, and Y F Poon, and W Foo, and S C Law, and S K O, and S Y Tung, and R Chappell
June 2005, Ai zheng = Aizheng = Chinese journal of cancer,
A W Lee, and D K Chan, and J F Fowler, and Y F Poon, and W Foo, and S C Law, and S K O, and S Y Tung, and R Chappell
July 1978, Radiology,
A W Lee, and D K Chan, and J F Fowler, and Y F Poon, and W Foo, and S C Law, and S K O, and S Y Tung, and R Chappell
January 2020, Cancer management and research,
A W Lee, and D K Chan, and J F Fowler, and Y F Poon, and W Foo, and S C Law, and S K O, and S Y Tung, and R Chappell
December 2008, Ai zheng = Aizheng = Chinese journal of cancer,
Copied contents to your clipboard!